<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1992-03-01" modified="2020-10-07" version="223">
<accession>P24928</accession>
<accession>A6NN93</accession>
<accession>B9EH88</accession>
<accession>Q6NX41</accession>
<name>RPB1_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="55">DNA-directed RNA polymerase II subunit RPB1</fullName>
<shortName>RNA polymerase II subunit B1</shortName>
<ecNumber>2.7.7.6</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DNA-directed RNA polymerase II subunit A</fullName>
</alternativeName>
<alternativeName>
<fullName>DNA-directed RNA polymerase III largest subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>RNA-directed RNA polymerase II subunit RPB1</fullName>
<ecNumber>2.7.7.48</ecNumber>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="57">POLR2A</name>
<name type="synonym">POLR2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Nucleic Acids Res." volume="20" first="910" last="910">
<title>Complete sequence of the human RNA polymerase II largest subunit.</title>
<authorList>
<person name="Wintzerith M."/>
<person name="Acker J."/>
<person name="Vicaire S."/>
<person name="Vigneron M."/>
<person name="Kedinger C."/>
</authorList>
<dbReference type="PubMed" id="1542581"/>
<dbReference type="DOI" id="10.1093/nar/20.4.910"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1995" name="Gene" volume="159" first="285" last="286">
<title>The human gene encoding the largest subunit of RNA polymerase II.</title>
<authorList>
<person name="Mita K."/>
<person name="Tsuji H."/>
<person name="Morimyo M."/>
<person name="Takahashi E."/>
<person name="Nenoi M."/>
<person name="Ichimura S."/>
<person name="Yamauchi M."/>
<person name="Hongo E."/>
<person name="Hayashi A."/>
</authorList>
<dbReference type="PubMed" id="7622068"/>
<dbReference type="DOI" id="10.1016/0378-1119(95)00081-g"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="440" first="1045" last="1049">
<title>DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.</title>
<authorList>
<person name="Zody M.C."/>
<person name="Garber M."/>
<person name="Adams D.J."/>
<person name="Sharpe T."/>
<person name="Harrow J."/>
<person name="Lupski J.R."/>
<person name="Nicholson C."/>
<person name="Searle S.M."/>
<person name="Wilming L."/>
<person name="Young S.K."/>
<person name="Abouelleil A."/>
<person name="Allen N.R."/>
<person name="Bi W."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Bugalter B.E."/>
<person name="Butler J."/>
<person name="Chang J.L."/>
<person name="Chen C.-K."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="Cuomo C.A."/>
<person name="de Jong P.J."/>
<person name="DeCaprio D."/>
<person name="Dewar K."/>
<person name="FitzGerald M."/>
<person name="Gilbert J."/>
<person name="Gibson R."/>
<person name="Gnerre S."/>
<person name="Goldstein S."/>
<person name="Grafham D.V."/>
<person name="Grocock R."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hart E."/>
<person name="Norman C.H."/>
<person name="Humphray S."/>
<person name="Jaffe D.B."/>
<person name="Jones M."/>
<person name="Kamal M."/>
<person name="Khodiyar V.K."/>
<person name="LaButti K."/>
<person name="Laird G."/>
<person name="Lehoczky J."/>
<person name="Liu X."/>
<person name="Lokyitsang T."/>
<person name="Loveland J."/>
<person name="Lui A."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews L."/>
<person name="Mauceli E."/>
<person name="McCarroll S.A."/>
<person name="Mihalev A.H."/>
<person name="Mudge J."/>
<person name="Nguyen C."/>
<person name="Nicol R."/>
<person name="O'Leary S.B."/>
<person name="Osoegawa K."/>
<person name="Schwartz D.C."/>
<person name="Shaw-Smith C."/>
<person name="Stankiewicz P."/>
<person name="Steward C."/>
<person name="Swarbreck D."/>
<person name="Venkataraman V."/>
<person name="Whittaker C.A."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Bradley A."/>
<person name="Hubbard T."/>
<person name="Birren B.W."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Nusbaum C."/>
</authorList>
<dbReference type="PubMed" id="16625196"/>
<dbReference type="DOI" id="10.1038/nature04689"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="34444" last="34453">
<title>Immunoaffinity purification and functional characterization of human transcription factor IIH and RNA polymerase II from clonal cell lines that conditionally express epitope-tagged subunits of the multiprotein complexes.</title>
<authorList>
<person name="Kershnar E."/>
<person name="Wu S.-Y."/>
<person name="Chiang C.-M."/>
</authorList>
<dbReference type="PubMed" id="9852112"/>
<dbReference type="DOI" id="10.1074/jbc.273.51.34444"/>
</citation>
<scope>FUNCTION</scope>
<scope>IDENTIFICATION IN THE RNA POLYMERASE II CORE-COMPLEX</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Nucleic Acids Res." volume="26" first="3542" last="3549">
<title>SAF-B couples transcription and pre-mRNA splicing to SAR/MAR elements.</title>
<authorList>
<person name="Nayler O."/>
<person name="Straetling W."/>
<person name="Bourquin J.-P."/>
<person name="Stagljar I."/>
<person name="Lindemann L."/>
<person name="Jasper H."/>
<person name="Hartmann A.M."/>
<person name="Fackelmeyer F.O."/>
<person name="Ullrich A."/>
<person name="Stamm S."/>
</authorList>
<dbReference type="PubMed" id="9671816"/>
<dbReference type="DOI" id="10.1093/nar/26.15.3542"/>
</citation>
<scope>INTERACTION WITH SAFB</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3688" last="3701">
<title>A novel RNA polymerase II-containing complex potentiates Tat-enhanced HIV-1 transcription.</title>
<authorList>
<person name="Parada C.A."/>
<person name="Roeder R.G."/>
</authorList>
<dbReference type="PubMed" id="10393184"/>
<dbReference type="DOI" id="10.1093/emboj/18.13.3688"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH HTATSF1; CCNT1; NCL; SUPT5H AND CDK9</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5960" last="5968">
<title>Tat-SF1 protein associates with RAP30 and human SPT5 proteins.</title>
<authorList>
<person name="Kim J.B."/>
<person name="Yamaguchi Y."/>
<person name="Wada T."/>
<person name="Handa H."/>
<person name="Sharp P.A."/>
</authorList>
<dbReference type="PubMed" id="10454543"/>
<dbReference type="DOI" id="10.1128/mcb.19.9.5960"/>
</citation>
<scope>INTERACTION WITH HTATSF1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2002" name="J. Mol. Biol." volume="323" first="411" last="416">
<title>The structure of an FF domain from human HYPA/FBP11.</title>
<authorList>
<person name="Allen M."/>
<person name="Friedler A."/>
<person name="Schon O."/>
<person name="Bycroft M."/>
</authorList>
<dbReference type="PubMed" id="12381297"/>
<dbReference type="DOI" id="10.1016/s0022-2836(02)00968-3"/>
</citation>
<scope>INTERACTION WITH FNBP3</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Mol. Cell. Proteomics" volume="1" first="598" last="610">
<title>Hyperphosphorylated C-terminal repeat domain-associating proteins in the nuclear proteome link transcription to DNA/chromatin modification and RNA processing.</title>
<authorList>
<person name="Carty S.M."/>
<person name="Greenleaf A.L."/>
</authorList>
<dbReference type="PubMed" id="12376575"/>
<dbReference type="DOI" id="10.1074/mcp.m200029-mcp200"/>
</citation>
<scope>INTERACTION WITH SYNCRIP</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="151" last="156">
<title>Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300.</title>
<authorList>
<person name="Rossow K.L."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="12527917"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206067"/>
</citation>
<scope>INTERACTION WITH DDX5</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Gene" volume="343" first="173" last="179">
<title>Transcriptional activity and substrate recognition of cyclin T2 from P-TEFb.</title>
<authorList>
<person name="Kurosu T."/>
<person name="Zhang F."/>
<person name="Peterlin B.M."/>
</authorList>
<dbReference type="PubMed" id="15563843"/>
<dbReference type="DOI" id="10.1016/j.gene.2004.08.027"/>
</citation>
<scope>INTERACTION WITH CCNT2</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="11639" last="11648">
<title>Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells.</title>
<authorList>
<person name="Yang L."/>
<person name="Li N."/>
<person name="Wang C."/>
<person name="Yu Y."/>
<person name="Yuan L."/>
<person name="Zhang M."/>
<person name="Cao X."/>
</authorList>
<dbReference type="PubMed" id="14684736"/>
<dbReference type="DOI" id="10.1074/jbc.m312895200"/>
</citation>
<scope>INTERACTION WITH CCNL2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="Mol. Cell" volume="13" first="587" last="597">
<title>Menin associates with a trithorax family histone methyltransferase complex and with the hoxc8 locus.</title>
<authorList>
<person name="Hughes C.M."/>
<person name="Rozenblatt-Rosen O."/>
<person name="Milne T.A."/>
<person name="Copeland T.D."/>
<person name="Levine S.S."/>
<person name="Lee J.C."/>
<person name="Hayes D.N."/>
<person name="Shanmugam K.S."/>
<person name="Bhattacharjee A."/>
<person name="Biondi C.A."/>
<person name="Kay G.F."/>
<person name="Hayward N.K."/>
<person name="Hess J.L."/>
<person name="Meyerson M."/>
</authorList>
<dbReference type="PubMed" id="14992727"/>
<dbReference type="DOI" id="10.1016/s1097-2765(04)00081-4"/>
</citation>
<scope>INTERACTION WITH MEN1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="Biochem. Biophys. Res. Commun." volume="334" first="61" last="68">
<title>Expression of the C-terminal domain of novel human SR-A1 protein: interaction with the CTD domain of RNA polymerase II.</title>
<authorList>
<person name="Katsarou M.E."/>
<person name="Papakyriakou A."/>
<person name="Katsaros N."/>
<person name="Scorilas A."/>
</authorList>
<dbReference type="PubMed" id="15992770"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2005.06.053"/>
</citation>
<scope>INTERACTION WITH SFRS19</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="35261" last="35271">
<title>Identification and characterization of a novel human histone H3 lysine 36 specific methyltransferase.</title>
<authorList>
<person name="Sun X.-J."/>
<person name="Wei J."/>
<person name="Wu X.-Y."/>
<person name="Hu M."/>
<person name="Wang L."/>
<person name="Wang H.-H."/>
<person name="Zhang Q.-H."/>
<person name="Chen S.-J."/>
<person name="Huang Q.-H."/>
<person name="Chen Z."/>
</authorList>
<dbReference type="PubMed" id="16118227"/>
<dbReference type="DOI" id="10.1074/jbc.m504012200"/>
</citation>
<scope>INTERACTION WITH SETD2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="17636" last="17641">
<title>Solution structure of the Set2-Rpb1 interacting domain of human Set2 and its interaction with the hyperphosphorylated C-terminal domain of Rpb1.</title>
<authorList>
<person name="Li M."/>
<person name="Phatnani H.P."/>
<person name="Guan Z."/>
<person name="Sage H."/>
<person name="Greenleaf A.L."/>
<person name="Zhou P."/>
</authorList>
<dbReference type="PubMed" id="16314571"/>
<dbReference type="DOI" id="10.1073/pnas.0506350102"/>
</citation>
<scope>INTERACTION WITH SETD2</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1909 AND TYR-1923</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Oncogene" volume="25" first="3247" last="3257">
<title>The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis.</title>
<authorList>
<person name="Moniaux N."/>
<person name="Nemos C."/>
<person name="Schmied B.M."/>
<person name="Chauhan S.C."/>
<person name="Deb S."/>
<person name="Morikane K."/>
<person name="Choudhury A."/>
<person name="Vanlith M."/>
<person name="Sutherlin M."/>
<person name="Sikela J.M."/>
<person name="Hollingsworth M.A."/>
<person name="Batra S.K."/>
</authorList>
<dbReference type="PubMed" id="16491129"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209353"/>
</citation>
<scope>INTERACTION WITH PAF1 IN PAF1/RNA POLYMERASE II</scope>
<source>
<tissue>Fetal pancreas</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="160" last="174">
<title>The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export.</title>
<authorList>
<person name="Yoh S.M."/>
<person name="Cho H."/>
<person name="Pickle L."/>
<person name="Evans R.M."/>
<person name="Jones K.A."/>
</authorList>
<dbReference type="PubMed" id="17234882"/>
<dbReference type="DOI" id="10.1101/gad.1503107"/>
</citation>
<scope>INTERACTION WITH SUPT6H</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="372" first="719" last="724">
<title>The human interferon-regulated ISG95 protein interacts with RNA polymerase II and shows methyltransferase activity.</title>
<authorList>
<person name="Haline-Vaz T."/>
<person name="Silva T.C.L."/>
<person name="Zanchin N.I.T."/>
</authorList>
<dbReference type="PubMed" id="18533109"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.05.137"/>
</citation>
<scope>INTERACTION WITH CMTR1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="22659" last="22669">
<title>Snapshots of the RNA processing factor SCAF8 bound to different phosphorylated forms of the carboxyl-terminal domain of RNA polymerase II.</title>
<authorList>
<person name="Becker R."/>
<person name="Loll B."/>
<person name="Meinhart A."/>
</authorList>
<dbReference type="PubMed" id="18550522"/>
<dbReference type="DOI" id="10.1074/jbc.m803540200"/>
</citation>
<scope>INTERACTION WITH SCAF8</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="J. Virol." volume="82" first="1118" last="1127">
<title>Transcription of hepatitis delta virus RNA by RNA polymerase II.</title>
<authorList>
<person name="Chang J."/>
<person name="Nie X."/>
<person name="Chang H.E."/>
<person name="Han Z."/>
<person name="Taylor J."/>
</authorList>
<dbReference type="PubMed" id="18032511"/>
<dbReference type="DOI" id="10.1128/jvi.01758-07"/>
</citation>
<scope>FUNCTION AS RNA-DIRECTED RNA POLYMERASE</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="609" last="618">
<title>Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes.</title>
<authorList>
<person name="Lee J.H."/>
<person name="Skalnik D.G."/>
</authorList>
<dbReference type="PubMed" id="17998332"/>
<dbReference type="DOI" id="10.1128/mcb.01356-07"/>
</citation>
<scope>INTERACTION WITH SETD1A; SETD1B AND WDR82</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1849; TYR-1874; SER-1896; TYR-1909; SER-1913; SER-1920; TYR-1923; SER-1927 AND SER-1934</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="5165" last="5174">
<title>MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity.</title>
<authorList>
<person name="Liu L."/>
<person name="Ishihara K."/>
<person name="Ichimura T."/>
<person name="Fujita N."/>
<person name="Hino S."/>
<person name="Tomita S."/>
<person name="Watanabe S."/>
<person name="Saitoh N."/>
<person name="Ito T."/>
<person name="Nakao M."/>
</authorList>
<dbReference type="PubMed" id="19106100"/>
<dbReference type="DOI" id="10.1074/jbc.m807098200"/>
</citation>
<scope>INTERACTION WITH ATF7IP</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="Mol. Cell" volume="34" first="387" last="393">
<title>TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II.</title>
<authorList>
<person name="Akhtar M.S."/>
<person name="Heidemann M."/>
<person name="Tietjen J.R."/>
<person name="Zhang D.W."/>
<person name="Chapman R.D."/>
<person name="Eick D."/>
<person name="Ansari A.Z."/>
</authorList>
<dbReference type="PubMed" id="19450536"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.04.016"/>
</citation>
<scope>PHOSPHORYLATION BY CDK7</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Mol. Cell. Biol." volume="29" first="5455" last="5464">
<title>TFIIH-associated Cdk7 kinase functions in phosphorylation of C-terminal domain Ser7 residues, promoter-proximal pausing, and termination by RNA polymerase II.</title>
<authorList>
<person name="Glover-Cutter K."/>
<person name="Larochelle S."/>
<person name="Erickson B."/>
<person name="Zhang C."/>
<person name="Shokat K."/>
<person name="Fisher R.P."/>
<person name="Bentley D.L."/>
</authorList>
<dbReference type="PubMed" id="19667075"/>
<dbReference type="DOI" id="10.1128/mcb.00637-09"/>
</citation>
<scope>PHOSPHORYLATION BY CDK7 AND CDK9</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="1260" last="1268">
<title>Binding to DNA of the RNA-polymerase II C-terminal domain allows discrimination between Cdk7 and Cdk9 phosphorylation.</title>
<authorList>
<person name="Lolli G."/>
</authorList>
<dbReference type="PubMed" id="19136461"/>
<dbReference type="DOI" id="10.1093/nar/gkn1061"/>
</citation>
<scope>PHOSPHORYLATION BY CDK7</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1843; THR-1854; SER-1878; SER-1882; SER-1899; SER-1913; SER-1917; SER-1920; SER-1927; SER-1931 AND SER-1934</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Mol. Cell. Biol." volume="30" first="2460" last="2472">
<title>RecQL5 promotes genome stabilization through two parallel mechanisms--interacting with RNA polymerase II and acting as a helicase.</title>
<authorList>
<person name="Islam M.N."/>
<person name="Fox D. III"/>
<person name="Guo R."/>
<person name="Enomoto T."/>
<person name="Wang W."/>
</authorList>
<dbReference type="PubMed" id="20231364"/>
<dbReference type="DOI" id="10.1128/mcb.01583-09"/>
</citation>
<scope>INTERACTION WITH RECQL5</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="Genes Dev." volume="25" first="972" last="983">
<title>The RNA polymerase II C-terminal domain promotes splicing activation through recruitment of a U2AF65-Prp19 complex.</title>
<authorList>
<person name="David C.J."/>
<person name="Boyne A.R."/>
<person name="Millhouse S.R."/>
<person name="Manley J.L."/>
</authorList>
<dbReference type="PubMed" id="21536736"/>
<dbReference type="DOI" id="10.1101/gad.2038011"/>
</citation>
<scope>INTERACTION WITH U2AF2</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="5012" last="5022">
<title>Transcription factor IIS cooperates with the E3 ligase UBR5 to ubiquitinate the CDK9 subunit of the positive transcription elongation factor B.</title>
<authorList>
<person name="Cojocaru M."/>
<person name="Bouchard A."/>
<person name="Cloutier P."/>
<person name="Cooper J.J."/>
<person name="Varzavand K."/>
<person name="Price D.H."/>
<person name="Coulombe B."/>
</authorList>
<dbReference type="PubMed" id="21127351"/>
<dbReference type="DOI" id="10.1074/jbc.m110.176628"/>
</citation>
<scope>PHOSPHORYLATION BY CDK9</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1917 AND SER-1931</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Science" volume="332" first="99" last="103">
<title>The C-terminal domain of RNA polymerase II is modified by site-specific methylation.</title>
<authorList>
<person name="Sims R.J. III"/>
<person name="Rojas L.A."/>
<person name="Beck D."/>
<person name="Bonasio R."/>
<person name="Schuller R."/>
<person name="Drury W.J. III"/>
<person name="Eick D."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="21454787"/>
<dbReference type="DOI" id="10.1126/science.1202663"/>
</citation>
<scope>METHYLATION AT ARG-1810 BY CARM1</scope>
<scope>MUTAGENESIS OF ARG-1810</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="Mol. Cell" volume="45" first="111" last="122">
<title>Ser7 phosphorylation of the CTD recruits the RPAP2 Ser5 phosphatase to snRNA genes.</title>
<authorList>
<person name="Egloff S."/>
<person name="Zaborowska J."/>
<person name="Laitem C."/>
<person name="Kiss T."/>
<person name="Murphy S."/>
</authorList>
<dbReference type="PubMed" id="22137580"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.11.006"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="586" last="592">
<title>Mutations in UVSSA cause UV-sensitive syndrome and impair RNA polymerase IIo processing in transcription-coupled nucleotide-excision repair.</title>
<authorList>
<person name="Nakazawa Y."/>
<person name="Sasaki K."/>
<person name="Mitsutake N."/>
<person name="Matsuse M."/>
<person name="Shimada M."/>
<person name="Nardo T."/>
<person name="Takahashi Y."/>
<person name="Ohyama K."/>
<person name="Ito K."/>
<person name="Mishima H."/>
<person name="Nomura M."/>
<person name="Kinoshita A."/>
<person name="Ono S."/>
<person name="Takenaka K."/>
<person name="Masuyama R."/>
<person name="Kudo T."/>
<person name="Slor H."/>
<person name="Utani A."/>
<person name="Tateishi S."/>
<person name="Yamashita S."/>
<person name="Stefanini M."/>
<person name="Lehmann A.R."/>
<person name="Yoshiura K.I."/>
<person name="Ogi T."/>
</authorList>
<dbReference type="PubMed" id="22466610"/>
<dbReference type="DOI" id="10.1038/ng.2229"/>
</citation>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="PLoS ONE" volume="7" first="E45749" last="E45749">
<title>Herpes simplex virus 1 ICP22 inhibits the transcription of viral gene promoters by binding to and blocking the recruitment of P-TEFb.</title>
<authorList>
<person name="Guo L."/>
<person name="Wu W.J."/>
<person name="Liu L.D."/>
<person name="Wang L.C."/>
<person name="Zhang Y."/>
<person name="Wu L.Q."/>
<person name="Guan Y."/>
<person name="Li Q.H."/>
</authorList>
<dbReference type="PubMed" id="23029222"/>
<dbReference type="DOI" id="10.1371/journal.pone.0045749"/>
</citation>
<scope>INTERACTION WITH HERPES SIMPLEX VIRUS 1 PROTEIN ICP22 (MICROBIAL INFECTION)</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-217; SER-1850; SER-1864; SER-1868; SER-1878; SER-1882; THR-1885; SER-1899; SER-1913; SER-1920; SER-1927 AND SER-1934</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="Mol. Cell" volume="52" first="314" last="324">
<title>Acetylation of RNA polymerase II regulates growth-factor-induced gene transcription in mammalian cells.</title>
<authorList>
<person name="Schroeder S."/>
<person name="Herker E."/>
<person name="Itzen F."/>
<person name="He D."/>
<person name="Thomas S."/>
<person name="Gilchrist D.A."/>
<person name="Kaehlcke K."/>
<person name="Cho S."/>
<person name="Pollard K.S."/>
<person name="Capra J.A."/>
<person name="Schnoelzer M."/>
<person name="Cole P.A."/>
<person name="Geyer M."/>
<person name="Bruneau B.G."/>
<person name="Adelman K."/>
<person name="Ott M."/>
</authorList>
<dbReference type="PubMed" id="24207025"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.10.009"/>
</citation>
<scope>ACETYLATION BY EP300</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="Mol. Cell. Biol." volume="33" first="406" last="417">
<title>Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response.</title>
<authorList>
<person name="Yuce O."/>
<person name="West S.C."/>
</authorList>
<dbReference type="PubMed" id="23149945"/>
<dbReference type="DOI" id="10.1128/mcb.01195-12"/>
</citation>
<scope>INTERACTION WITH SETX</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="Nat. Commun." volume="4" first="1830" last="1830">
<title>GANP regulates recruitment of AID to immunoglobulin variable regions by modulating transcription and nucleosome occupancy.</title>
<authorList>
<person name="Singh S.K."/>
<person name="Maeda K."/>
<person name="Eid M.M."/>
<person name="Almofty S.A."/>
<person name="Ono M."/>
<person name="Pham P."/>
<person name="Goodman M.F."/>
<person name="Sakaguchi N."/>
</authorList>
<dbReference type="PubMed" id="23652018"/>
<dbReference type="DOI" id="10.1038/ncomms2823"/>
</citation>
<scope>INTERACTION WITH MCM3AP</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2014" name="Cell Rep." volume="7" first="19" last="26">
<title>Phosphorylation-dependent PIH1D1 interactions define substrate specificity of the R2TP cochaperone complex.</title>
<authorList>
<person name="Horejsi Z."/>
<person name="Stach L."/>
<person name="Flower T.G."/>
<person name="Joshi D."/>
<person name="Flynn H."/>
<person name="Skehel J.M."/>
<person name="O'Reilly N.J."/>
<person name="Ogrodowicz R.W."/>
<person name="Smerdon S.J."/>
<person name="Boulton S.J."/>
</authorList>
<dbReference type="PubMed" id="24656813"/>
<dbReference type="DOI" id="10.1016/j.celrep.2014.03.013"/>
</citation>
<scope>INTERACTION WITH PIH1D1</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-1874; SER-1906; TYR-1909 AND TYR-1923</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="50">
<citation type="journal article" date="2015" name="Elife" volume="4">
<title>Methylation of RNA polymerase II non-consensus Lysine residues marks early transcription in mammalian cells.</title>
<authorList>
<person name="Dias J.D."/>
<person name="Rito T."/>
<person name="Torlai Triglia E."/>
<person name="Kukalev A."/>
<person name="Ferrai C."/>
<person name="Chotalia M."/>
<person name="Brookes E."/>
<person name="Kimura H."/>
<person name="Pombo A."/>
</authorList>
<dbReference type="PubMed" id="26687004"/>
<dbReference type="DOI" id="10.7554/elife.11215"/>
</citation>
<scope>METHYLATION</scope>
<scope>ACETYLATION</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2015" name="Transcription" volume="6" first="91" last="101">
<title>Site-specific methylation and acetylation of lysine residues in the C-terminal domain (CTD) of RNA polymerase II.</title>
<authorList>
<person name="Voss K."/>
<person name="Forne I."/>
<person name="Descostes N."/>
<person name="Hintermair C."/>
<person name="Schueller R."/>
<person name="Maqbool M.A."/>
<person name="Heidemann M."/>
<person name="Flatley A."/>
<person name="Imhof A."/>
<person name="Gut M."/>
<person name="Gut I."/>
<person name="Kremmer E."/>
<person name="Andrau J.C."/>
<person name="Eick D."/>
</authorList>
<dbReference type="PubMed" id="26566685"/>
<dbReference type="DOI" id="10.1080/21541264.2015.1114983"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ACETYLATION AT LYS-1866; LYS-1887; LYS-1922 AND LYS-1936</scope>
<scope>METHYLATION AT LYS-1859; LYS-1866; LYS-1873; LYS-1887; LYS-1922 AND LYS-1936</scope>
<scope>PHOSPHORYLATION AT THR-1840; SER-1843; SER-1845; SER-1849; SER-1850; SER-1857; TYR-1860; SER-1861; THR-1863; SER-1864; TYR-1867; THR-1870; TYR-1874; SER-1875; THR-1877; SER-1878; TYR-1881; SER-1882; TYR-1909; THR-1912; SER-1913; THR-1915; TYR-1916; SER-1917; THR-1919; SER-1920; TYR-1923; THR-1926; SER-1927; THR-1929; TYR-1930; SER-1931; THR-1933 AND SER-1934</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="8608" last="8613">
<title>FUS functions in coupling transcription to splicing by mediating an interaction between RNAP II and U1 snRNP.</title>
<authorList>
<person name="Yu Y."/>
<person name="Reed R."/>
</authorList>
<dbReference type="PubMed" id="26124092"/>
<dbReference type="DOI" id="10.1073/pnas.1506282112"/>
</citation>
<scope>INTERACTION WITH FUS</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2016" name="Nature" volume="529" first="48" last="53">
<title>SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination.</title>
<authorList>
<person name="Yanling Zhao D."/>
<person name="Gish G."/>
<person name="Braunschweig U."/>
<person name="Li Y."/>
<person name="Ni Z."/>
<person name="Schmitges F.W."/>
<person name="Zhong G."/>
<person name="Liu K."/>
<person name="Li W."/>
<person name="Moffat J."/>
<person name="Vedadi M."/>
<person name="Min J."/>
<person name="Pawson T.J."/>
<person name="Blencowe B.J."/>
<person name="Greenblatt J.F."/>
</authorList>
<dbReference type="PubMed" id="26700805"/>
<dbReference type="DOI" id="10.1038/nature16469"/>
</citation>
<scope>INTERACTION WITH TDRD3; PRMT5; SETX; SMN1 AND XRN2</scope>
<scope>METHYLATION AT ARG-1603 AND ARG-1810</scope>
<scope>MUTAGENESIS OF ARG-1810</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2017" name="Cell Rep." volume="18" first="334" last="343">
<title>Transcription Dynamics Prevent RNA-Mediated Genomic Instability through SRPK2-Dependent DDX23 Phosphorylation.</title>
<authorList>
<person name="Sridhara S.C."/>
<person name="Carvalho S."/>
<person name="Grosso A.R."/>
<person name="Gallego-Paez L.M."/>
<person name="Carmo-Fonseca M."/>
<person name="de Almeida S.F."/>
</authorList>
<dbReference type="PubMed" id="28076779"/>
<dbReference type="DOI" id="10.1016/j.celrep.2016.12.050"/>
</citation>
<scope>INTERACTION WITH POLR2A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2006" name="Mol. Cell" volume="24" first="759" last="770">
<title>Determinants for dephosphorylation of the RNA polymerase II C-terminal domain by Scp1.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Kim Y."/>
<person name="Genoud N."/>
<person name="Gao J."/>
<person name="Kelly J.W."/>
<person name="Pfaff S.L."/>
<person name="Gill G.N."/>
<person name="Dixon J.E."/>
<person name="Noel J.P."/>
</authorList>
<dbReference type="PubMed" id="17157258"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.10.027"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1796-1803 IN COMPLEX WITH CTDSP1</scope>
<scope>DEPHOSPHORYLATION</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2013" name="Nat. Struct. Mol. Biol." volume="20" first="892" last="899">
<title>Structural mimicry in transcription regulation of human RNA polymerase II by the DNA helicase RECQL5.</title>
<authorList>
<person name="Kassube S.A."/>
<person name="Jinek M."/>
<person name="Fang J."/>
<person name="Tsutakawa S."/>
<person name="Nogales E."/>
</authorList>
<dbReference type="PubMed" id="23748380"/>
<dbReference type="DOI" id="10.1038/nsmb.2596"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY IN COMPLEX WITH RECQL5</scope>
<scope>INTERACTION WITH RECQL5 AND TCEA1</scope>
<scope>SUBUNIT</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2019" name="Am. J. Hum. Genet." volume="105" first="283" last="301">
<title>De Novo Heterozygous POLR2A Variants Cause a Neurodevelopmental Syndrome with Profound Infantile-Onset Hypotonia.</title>
<authorList>
<person name="Haijes H.A."/>
<person name="Koster M.J.E."/>
<person name="Rehmann H."/>
<person name="Li D."/>
<person name="Hakonarson H."/>
<person name="Cappuccio G."/>
<person name="Hancarova M."/>
<person name="Lehalle D."/>
<person name="Reardon W."/>
<person name="Schaefer G.B."/>
<person name="Lehman A."/>
<person name="van de Laar I.M.B.H."/>
<person name="Tesselaar C.D."/>
<person name="Turner C."/>
<person name="Goldenberg A."/>
<person name="Patrier S."/>
<person name="Thevenon J."/>
<person name="Pinelli M."/>
<person name="Brunetti-Pierri N."/>
<person name="Prchalova D."/>
<person name="Havlovicova M."/>
<person name="Vlckova M."/>
<person name="Sedlacek Z."/>
<person name="Lopez E."/>
<person name="Ragoussis V."/>
<person name="Pagnamenta A.T."/>
<person name="Kini U."/>
<person name="Vos H.R."/>
<person name="van Es R.M."/>
<person name="van Schaik R.F.M.A."/>
<person name="van Essen T.A.J."/>
<person name="Kibaek M."/>
<person name="Taylor J.C."/>
<person name="Sullivan J."/>
<person name="Shashi V."/>
<person name="Petrovski S."/>
<person name="Fagerberg C."/>
<person name="Martin D.M."/>
<person name="van Gassen K.L.I."/>
<person name="Pfundt R."/>
<person name="Falk M.J."/>
<person name="McCormick E.M."/>
<person name="Timmers H.T.M."/>
<person name="van Hasselt P.M."/>
</authorList>
<dbReference type="PubMed" id="31353023"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2019.06.016"/>
</citation>
<scope>INVOLVEMENT IN NEDHIB</scope>
<scope>VARIANTS NEDHIB LEU-371; THR-457; SER-531; TYR-669 DEL; 700-GLN--ASN-1970 DEL; 735-GLN--ASN-1970 DEL; MET-736; SER-755 DEL; THR-769; THR-848; HIS-1109; PRO-1124; LYS-1125 DEL; SER-1251 AND HIS-1603</scope>
<scope>CHARACTERIZATION OF VARIANTS NEDHIB THR-457; SER-531; MET-736; SER-755 DEL; PRO-1124; SER-1251 AND HIS-1603</scope>
<scope>MUTAGENESIS OF 812-LYS--ASN-1970</scope>
</reference>
<comment type="function">
<text evidence="10 33 42 43 45 52">DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Forms the polymerase active center together with the second largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol II. A bridging helix emanates from RPB1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol II by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition. During transcription elongation, Pol II moves on the template as the transcript elongates. Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II largest subunit (RPB1), which serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing. Regulation of gene expression levels depends on the balance between methylation and acetylation levels of tha CTD-lysines (By similarity). Initiation or early elongation steps of transcription of growth-factors-induced immediate early genes are regulated by the acetylation status of the CTD (PubMed:24207025). Methylation and dimethylation have a repressive effect on target genes expression (By similarity).</text>
</comment>
<comment type="function">
<text evidence="26">(Microbial infection) Acts as an RNA-dependent RNA polymerase when associated with small delta antigen of Hepatitis delta virus, acting both as a replicate and transcriptase for the viral RNA circular genome.</text>
</comment>
<comment type="catalytic activity">
<reaction>
<text>a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate + RNA(n+1)</text>
<dbReference type="Rhea" id="RHEA:21248"/>
<dbReference type="Rhea" id="RHEA-COMP:11128"/>
<dbReference type="Rhea" id="RHEA-COMP:11129"/>
<dbReference type="ChEBI" id="CHEBI:33019"/>
<dbReference type="ChEBI" id="CHEBI:61557"/>
<dbReference type="ChEBI" id="CHEBI:83400"/>
<dbReference type="EC" id="2.7.7.6"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction>
<text>a ribonucleoside 5'-triphosphate + RNA(n) = diphosphate + RNA(n+1)</text>
<dbReference type="Rhea" id="RHEA:21248"/>
<dbReference type="Rhea" id="RHEA-COMP:11128"/>
<dbReference type="Rhea" id="RHEA-COMP:11129"/>
<dbReference type="ChEBI" id="CHEBI:33019"/>
<dbReference type="ChEBI" id="CHEBI:61557"/>
<dbReference type="ChEBI" id="CHEBI:83400"/>
<dbReference type="EC" id="2.7.7.48"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 27 28 29 33 36 40 41 42 44 45 48 49 51 52">Component of the RNA polymerase II (Pol II) complex consisting of 12 subunits. Component of a complex which is at least composed of HTATSF1/Tat-SF1, the P-TEFb complex components CDK9 and CCNT1, RNA polymerase II, SUPT5H, and NCL/nucleolin. The large PER complex involved in the repression of transcriptional termination is composed of at least PER2, CDK9, DDX5, DHX9, NCBP1 and POLR2A (active). Interacts (via the C-terminal domain (CTD)) with U2AF2; recruits PRPF19 and the Prp19 complex to the pre-mRNA and may couple transcription to pre-mRNA splicing. Interacts (via the C-terminal domain (CTD)) with SMN1/SMN2; recruits SMN1/SMN2 to RNA Pol II elongation complexes. Interacts via the phosphorylated C-terminal domain with WDR82 and with SETD1A and SETD1B only in the presence of WDR82. When phosphorylated at 'Ser-5', interacts with MEN1; the unphosphorylated form, or phosphorylated at 'Ser-2' does not interact. When phosphorylated at 'Ser-2', interacts with SUPT6H (via SH2 domain). Interacts with RECQL5 and TCEA1; binding of RECQL5 prevents TCEA1 binding. The phosphorylated C-terminal domain interacts with FNBP3 and SYNCRIP. Interacts with ATF7IP. Interacts with DDX5. Interacts with WWP2. Interacts with SETX. Interacts (phosphorylated) with PIH1D1. Interacts (via the C-terminal domain (CTD)) with TDRD3. Interacts with PRMT5. Interacts with XRN2. Interacts with SAFB/SAFB1. Interacts with CCNL1. Interacts with CCNL2, MYO1C, PAF1 and SFRS19. Interacts (via C-terminus) with CMTR1, CTDSP1 and SCAF8. Interacts (via the C-terminal domain (CTD)) with CCNT2 (PubMed:15563843). Interacts with FUS. Interacts with MCM3AP isoform GANP (PubMed:23652018). Interacts with kinase SRPK2; the interaction occurs during the co-transcriptional formation of inappropriate R-loops (PubMed:28076779).</text>
</comment>
<comment type="subunit">
<text evidence="39">(Microbial infection) Interacts with herpes simplex virus 1 protein ICP22; this interaction causes loss of CTD 'Ser-2' phosphorylation from pol II engaged in transcription (PubMed:23029222).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-6425205">
<id>Q9NWX5</id>
<label>ASB6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-930143">
<id>Q6P1J9</id>
<label>CDC73</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-351962">
<id>P17844</id>
<label>DDX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-15569571">
<id>Q9UPY3-1</id>
<label>DICER1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-2607770">
<id>Q8N7H5</id>
<label>PAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-351098">
<id>O14744</id>
<label>PRMT5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-15710057">
<id>O94762-1</id>
<label>RECQL5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-1053506">
<id>Q96P16</id>
<label>RPRD1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-747925">
<id>Q9NQG5</id>
<label>RPRD1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-1220123">
<id>Q7Z333</id>
<label>SETX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-395421">
<id>Q16637</id>
<label>SMN2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-747719">
<id>Q96H20</id>
<label>SNF8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-710464">
<id>O00267</id>
<label>SUPT5H</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-2608271">
<id>P23193</id>
<label>TCEA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-3938232">
<id>Q9H7E2</id>
<label>TDRD3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-295232">
<id>Q9HCS7</id>
<label>XAB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-14033488">
<id>Q98140</id>
<label>ORF24</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-11712334">
<id>L8B1Q7</id>
<label>ORF6</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-295301">
<id>P24928</id>
</interactant>
<interactant intactId="EBI-11514477">
<id>Q67020</id>
<label>PA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="46 49 52">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="46">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="49">Chromosome</location>
</subcellularLocation>
<text evidence="46 49">Hypophosphorylated form is mainly found in the cytoplasm, while the hyperphosphorylated and active form is nuclear (PubMed:26566685). Co-localizes with kinase SRPK2 and helicase DDX23 at chromatin loci where unscheduled R-loops form (PubMed:28076779).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P24928-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P24928-2</id>
<name>2</name>
<sequence type="described" ref="VSP_056184 VSP_056185"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="54">The C-terminal domain (CTD) serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing.</text>
</comment>
<comment type="PTM">
<text evidence="23 24 30 31 32 34 37 46 49">The tandem heptapeptide repeats in the C-terminal domain (CTD) can be highly phosphorylated (PubMed:28076779). The phosphorylation activates Pol II. Phosphorylation occurs mainly at residues 'Ser-2' and 'Ser-5' of the heptapeptide repeat and is mediated, at least, by CDK7 and CDK9. CDK7 phosphorylation of POLR2A associated with DNA promotes transcription initiation by triggering dissociation from DNA. Phosphorylation also takes place at 'Ser-7' of the heptapeptide repeat, which is required for efficient transcription of snRNA genes and processing of the transcripts. The phosphorylation state is believed to result from the balanced action of site-specific CTD kinases and phosphatases, and a 'CTD code' that specifies the position of Pol II within the transcription cycle has been proposed. Dephosphorylated by the protein phosphatase CTDSP1.</text>
</comment>
<comment type="PTM">
<text evidence="43 46 47">Among tandem heptapeptide repeats of the C-terminal domain (CTD) some do not match the Y-S-P-T-S-P-S consensus, the seventh serine residue 'Ser-7' being replaced by a lysine. 'Lys-7' in these non-consensus heptapeptide repeats can be alternatively acetylated, methylated and dimethylated. EP300 is one of the enzyme able to acetylate 'Lys-7'. Acetylation at 'Lys-7' of non-consensus heptapeptide repeats is associated with 'Ser-2' phosphorylation and active transcription. Regulates initiation or early elongation steps of transcription specially for inducible genes.</text>
</comment>
<comment type="PTM">
<text evidence="10 46 47 48">Methylated at Arg-1810 prior to transcription initiation when the CTD is hypophosphorylated, phosphorylation at Ser-1805 and Ser-1808 preventing this methylation. Symmetrically or asymmetrically dimethylated at Arg-1810 by PRMT5 and CARM1 respectively. Symmetric or asymmetric dimethylation modulates interactions with CTD-binding proteins like SMN1/SMN2 and TDRD3. SMN1/SMN2 interacts preferentially with the symmetrically dimethylated form while TDRD3 interacts with the asymmetric form. Through the recruitment of SMN1/SMN2, symmetric dimethylation is required for resolving RNA-DNA hybrids created by RNA polymerase II, that form R-loop in transcription terminal regions, an important step in proper transcription termination. CTD dimethylation may also facilitate the expression of select RNAs. Among tandem heptapeptide repeats of the C-terminal domain (CTD) some do not match the Y-S-P-T-S-P-S consensus, the seventh serine residue 'Ser-7' being replaced by a lysine. 'Lys-7' in these non-consensus heptapeptide repeats can be alternatively acetylated, methylated, dimethylated and trimethylated. Methylation occurs in the earliest transcription stages and precedes or is concomitant to 'Ser-5' and 'Ser-7' phosphorylation. Dimethylation and trimehtylation at 'Lys-7' of non-consensus heptapeptide repeats are exclusively associated with phosphorylated CTD.</text>
</comment>
<comment type="PTM">
<text evidence="10 38">Ubiquitinated by WWP2 leading to proteasomal degradation (By similarity). Following UV treatment, the elongating form of RNA polymerase II (RNA pol IIo) is ubiquitinated on UV damage sites without leading to degradation: ubiquitination is facilitated by KIAA1530/UVSSA and promotes RNA pol IIo backtracking to allow access to the nucleotide excision repair machinery.</text>
</comment>
<comment type="disease" evidence="50">
<disease id="DI-05667">
<name>Neurodevelopmental disorder with hypotonia and variable intellectual and behavioral abnormalities</name>
<acronym>NEDHIB</acronym>
<description>An autosomal dominant neurodevelopmental disorder characterized by profound infantile-onset hypotonia, developmental delay with poor speech, delayed walking, and impaired intellectual development. Additional variable features include feeding difficulties, dysmorphic features, and visual defects.</description>
<dbReference type="MIM" id="618603"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>The binding of ribonucleoside triphosphate to the RNA polymerase II transcribing complex probably involves a two-step mechanism. The initial binding seems to occur at the entry (E) site and involves a magnesium ion temporarily coordinated by three conserved aspartate residues of the two largest RNA Pol II subunits. The ribonucleoside triphosphate is transferred by a rotation to the nucleotide addition (A) site for pairing with the template DNA. The catalytic A site involves three conserved aspartate residues of the RNA Pol II largest subunit which permanently coordinate a second magnesium ion.</text>
</comment>
<comment type="similarity">
<text evidence="55">Belongs to the RNA polymerase beta' chain family.</text>
</comment>
<dbReference type="EC" id="2.7.7.6"/>
<dbReference type="EC" id="2.7.7.48"/>
<dbReference type="EMBL" id="X63564">
<property type="protein sequence ID" value="CAA45125.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X74874">
<property type="protein sequence ID" value="CAA52862.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X74873">
<property type="protein sequence ID" value="CAA52862.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X74872">
<property type="protein sequence ID" value="CAA52862.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X74871">
<property type="protein sequence ID" value="CAA52862.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X74870">
<property type="protein sequence ID" value="CAA52862.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC113189">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471108">
<property type="protein sequence ID" value="EAW90181.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC067295">
<property type="protein sequence ID" value="AAH67295.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC137231">
<property type="protein sequence ID" value="AAI37232.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PIR" id="I38186">
<property type="entry name" value="I38186"/>
</dbReference>
<dbReference type="PIR" id="S21054">
<property type="entry name" value="S21054"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000928.1">
<property type="nucleotide sequence ID" value="NM_000937.4"/>
</dbReference>
<dbReference type="PDB" id="2GHQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="C/D=1795-1803"/>
</dbReference>
<dbReference type="PDB" id="2GHT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="C/D=1796-1803"/>
</dbReference>
<dbReference type="PDB" id="2LTO">
<property type="method" value="NMR"/>
<property type="chains" value="B=1804-1816"/>
</dbReference>
<dbReference type="PDB" id="3D9K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="Y/Z=1790-1803"/>
</dbReference>
<dbReference type="PDB" id="3D9L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="Y/Z=1790-1803"/>
</dbReference>
<dbReference type="PDB" id="3D9M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="Y/Z=1790-1803"/>
</dbReference>
<dbReference type="PDB" id="3D9N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="Y/Z=1790-1803"/>
</dbReference>
<dbReference type="PDB" id="3D9O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="Z=1790-1803"/>
</dbReference>
<dbReference type="PDB" id="3D9P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="Y/Z=1790-1803"/>
</dbReference>
<dbReference type="PDB" id="4JXT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B=1787-1805"/>
</dbReference>
<dbReference type="PDB" id="5IY6">
<property type="method" value="EM"/>
<property type="resolution" value="7.20"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5IY7">
<property type="method" value="EM"/>
<property type="resolution" value="8.60"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5IY8">
<property type="method" value="EM"/>
<property type="resolution" value="7.90"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5IY9">
<property type="method" value="EM"/>
<property type="resolution" value="6.30"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5IYA">
<property type="method" value="EM"/>
<property type="resolution" value="5.40"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5IYB">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5IYC">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5IYD">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="5M3H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="X/Y=1713-1740"/>
</dbReference>
<dbReference type="PDB" id="5M3J">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="X=1713-1740"/>
</dbReference>
<dbReference type="PDB" id="6DRD">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDB" id="6F5P">
<property type="method" value="X-ray"/>
<property type="resolution" value="4.14"/>
<property type="chains" value="G=1713-1740"/>
</dbReference>
<dbReference type="PDB" id="6G0R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.25"/>
<property type="chains" value="C=772-782"/>
</dbReference>
<dbReference type="PDB" id="6O9L">
<property type="method" value="EM"/>
<property type="resolution" value="7.20"/>
<property type="chains" value="A=1-1970"/>
</dbReference>
<dbReference type="PDBsum" id="2GHQ"/>
<dbReference type="PDBsum" id="2GHT"/>
<dbReference type="PDBsum" id="2LTO"/>
<dbReference type="PDBsum" id="3D9K"/>
<dbReference type="PDBsum" id="3D9L"/>
<dbReference type="PDBsum" id="3D9M"/>
<dbReference type="PDBsum" id="3D9N"/>
<dbReference type="PDBsum" id="3D9O"/>
<dbReference type="PDBsum" id="3D9P"/>
<dbReference type="PDBsum" id="4JXT"/>
<dbReference type="PDBsum" id="5IY6"/>
<dbReference type="PDBsum" id="5IY7"/>
<dbReference type="PDBsum" id="5IY8"/>
<dbReference type="PDBsum" id="5IY9"/>
<dbReference type="PDBsum" id="5IYA"/>
<dbReference type="PDBsum" id="5IYB"/>
<dbReference type="PDBsum" id="5IYC"/>
<dbReference type="PDBsum" id="5IYD"/>
<dbReference type="PDBsum" id="5M3H"/>
<dbReference type="PDBsum" id="5M3J"/>
<dbReference type="PDBsum" id="6DRD"/>
<dbReference type="PDBsum" id="6F5P"/>
<dbReference type="PDBsum" id="6G0R"/>
<dbReference type="PDBsum" id="6O9L"/>
<dbReference type="SMR" id="P24928"/>
<dbReference type="BioGRID" id="111426">
<property type="interactions" value="355"/>
</dbReference>
<dbReference type="CORUM" id="P24928"/>
<dbReference type="DIP" id="DIP-29011N"/>
<dbReference type="IntAct" id="P24928">
<property type="interactions" value="113"/>
</dbReference>
<dbReference type="MINT" id="P24928"/>
<dbReference type="STRING" id="9606.ENSP00000480158"/>
<dbReference type="BindingDB" id="P24928"/>
<dbReference type="ChEMBL" id="CHEMBL1641353"/>
<dbReference type="iPTMnet" id="P24928"/>
<dbReference type="MetOSite" id="P24928"/>
<dbReference type="PhosphoSitePlus" id="P24928"/>
<dbReference type="BioMuta" id="POLR2A"/>
<dbReference type="DMDM" id="281185484"/>
<dbReference type="EPD" id="P24928"/>
<dbReference type="jPOST" id="P24928"/>
<dbReference type="MassIVE" id="P24928"/>
<dbReference type="MaxQB" id="P24928"/>
<dbReference type="PaxDb" id="P24928"/>
<dbReference type="PeptideAtlas" id="P24928"/>
<dbReference type="PRIDE" id="P24928"/>
<dbReference type="ProteomicsDB" id="54240">
<molecule id="P24928-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="66745"/>
<dbReference type="Antibodypedia" id="3208">
<property type="antibodies" value="808 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000572844">
<molecule id="P24928-2"/>
<property type="protein sequence ID" value="ENSP00000461879"/>
<property type="gene ID" value="ENSG00000181222"/>
</dbReference>
<dbReference type="GeneID" id="5430"/>
<dbReference type="KEGG" id="hsa:5430"/>
<dbReference type="UCSC" id="uc002ghe.4">
<molecule id="P24928-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5430"/>
<dbReference type="DisGeNET" id="5430"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000181222.14"/>
<dbReference type="GeneCards" id="POLR2A"/>
<dbReference type="HGNC" id="HGNC:9187">
<property type="gene designation" value="POLR2A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000181222">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="POLR2A"/>
<dbReference type="MIM" id="180660">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="618603">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P24928"/>
<dbReference type="OpenTargets" id="ENSG00000181222"/>
<dbReference type="PharmGKB" id="PA33507"/>
<dbReference type="eggNOG" id="KOG0260">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00930000151033"/>
<dbReference type="HOGENOM" id="CLU_000487_3_1_1"/>
<dbReference type="InParanoid" id="P24928"/>
<dbReference type="KO" id="K03006"/>
<dbReference type="OrthoDB" id="591636at2759"/>
<dbReference type="PhylomeDB" id="P24928"/>
<dbReference type="TreeFam" id="TF103036"/>
<dbReference type="PathwayCommons" id="P24928"/>
<dbReference type="Reactome" id="R-HSA-112382">
<property type="pathway name" value="Formation of RNA Pol II elongation complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-113418">
<property type="pathway name" value="Formation of the Early Elongation Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167152">
<property type="pathway name" value="Formation of HIV elongation complex in the absence of HIV Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167158">
<property type="pathway name" value="Formation of the HIV-1 Early Elongation Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167160">
<property type="pathway name" value="RNA Pol II CTD phosphorylation and interaction with CE during HIV infection"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167161">
<property type="pathway name" value="HIV Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167162">
<property type="pathway name" value="RNA Polymerase II HIV Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167172">
<property type="pathway name" value="Transcription of the HIV genome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167200">
<property type="pathway name" value="Formation of HIV-1 elongation complex containing HIV-1 Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167238">
<property type="pathway name" value="Pausing and recovery of Tat-mediated HIV elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167242">
<property type="pathway name" value="Abortive elongation of HIV-1 transcript in the absence of Tat"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167243">
<property type="pathway name" value="Tat-mediated HIV elongation arrest and recovery"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167246">
<property type="pathway name" value="Tat-mediated elongation of the HIV-1 transcript"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167287">
<property type="pathway name" value="HIV elongation arrest and recovery"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-167290">
<property type="pathway name" value="Pausing and recovery of HIV elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168325">
<property type="pathway name" value="Viral Messenger RNA Synthesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-203927">
<property type="pathway name" value="MicroRNA (miRNA) biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5578749">
<property type="pathway name" value="Transcriptional regulation by small RNAs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5601884">
<property type="pathway name" value="PIWI-interacting RNA (piRNA) biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-674695">
<property type="pathway name" value="RNA Polymerase II Pre-transcription Events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6781823">
<property type="pathway name" value="Formation of TC-NER Pre-Incision Complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6781827">
<property type="pathway name" value="Transcription-Coupled Nucleotide Excision Repair (TC-NER)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6782135">
<property type="pathway name" value="Dual incision in TC-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6782210">
<property type="pathway name" value="Gap-filling DNA repair synthesis and ligation in TC-NER"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6796648">
<property type="pathway name" value="TP53 Regulates Transcription of DNA Repair Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6803529">
<property type="pathway name" value="FGFR2 alternative splicing"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6807505">
<property type="pathway name" value="RNA polymerase II transcribes snRNA genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72086">
<property type="pathway name" value="mRNA Capping"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72163">
<property type="pathway name" value="mRNA Splicing - Major Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72165">
<property type="pathway name" value="mRNA Splicing - Minor Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-72203">
<property type="pathway name" value="Processing of Capped Intron-Containing Pre-mRNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73776">
<property type="pathway name" value="RNA Polymerase II Promoter Escape"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-73779">
<property type="pathway name" value="RNA Polymerase II Transcription Pre-Initiation And Promoter Opening"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75953">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75955">
<property type="pathway name" value="RNA Polymerase II Transcription Elongation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-76042">
<property type="pathway name" value="RNA Polymerase II Transcription Initiation And Promoter Clearance"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-77075">
<property type="pathway name" value="RNA Pol II CTD phosphorylation and interaction with CE"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8851708">
<property type="pathway name" value="Signaling by FGFR2 IIIa TM"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9018519">
<property type="pathway name" value="Estrogen-dependent gene expression"/>
</dbReference>
<dbReference type="SIGNOR" id="P24928"/>
<dbReference type="BioGRID-ORCS" id="5430">
<property type="hits" value="756 hits in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="POLR2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P24928"/>
<dbReference type="GeneWiki" id="POLR2A"/>
<dbReference type="GenomeRNAi" id="5430"/>
<dbReference type="Pharos" id="P24928">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P24928"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="P24928">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000181222">
<property type="expression patterns" value="Expressed in testis and 234 other tissues"/>
</dbReference>
<dbReference type="Genevisible" id="P24928">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005665">
<property type="term" value="C:RNA polymerase II, core complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003677">
<property type="term" value="F:DNA binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0003899">
<property type="term" value="F:DNA-directed 5'-3' RNA polymerase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:1990841">
<property type="term" value="F:promoter-specific chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008022">
<property type="term" value="F:protein C-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003968">
<property type="term" value="F:RNA-directed 5'-3' RNA polymerase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006370">
<property type="term" value="P:7-methylguanosine mRNA capping"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006353">
<property type="term" value="P:DNA-templated transcription, termination"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008543">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000398">
<property type="term" value="P:mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033120">
<property type="term" value="P:positive regulation of RNA splicing"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050434">
<property type="term" value="P:positive regulation of viral transcription"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060964">
<property type="term" value="P:regulation of gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016070">
<property type="term" value="P:RNA metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042795">
<property type="term" value="P:snRNA transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035019">
<property type="term" value="P:somatic stem cell population maintenance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006366">
<property type="term" value="P:transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006368">
<property type="term" value="P:transcription elongation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006367">
<property type="term" value="P:transcription initiation from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006283">
<property type="term" value="P:transcription-coupled nucleotide-excision repair"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="DisProt" id="DP01284"/>
<dbReference type="Gene3D" id="1.10.132.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.274.100">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.1360.140">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00126"/>
<dbReference type="InterPro" id="IPR000722">
<property type="entry name" value="RNA_pol_asu"/>
</dbReference>
<dbReference type="InterPro" id="IPR000684">
<property type="entry name" value="RNA_pol_II_repeat_euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR006592">
<property type="entry name" value="RNA_pol_N"/>
</dbReference>
<dbReference type="InterPro" id="IPR007080">
<property type="entry name" value="RNA_pol_Rpb1_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007066">
<property type="entry name" value="RNA_pol_Rpb1_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR042102">
<property type="entry name" value="RNA_pol_Rpb1_3_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR007083">
<property type="entry name" value="RNA_pol_Rpb1_4"/>
</dbReference>
<dbReference type="InterPro" id="IPR007081">
<property type="entry name" value="RNA_pol_Rpb1_5"/>
</dbReference>
<dbReference type="InterPro" id="IPR007075">
<property type="entry name" value="RNA_pol_Rpb1_6"/>
</dbReference>
<dbReference type="InterPro" id="IPR007073">
<property type="entry name" value="RNA_pol_Rpb1_7"/>
</dbReference>
<dbReference type="InterPro" id="IPR038593">
<property type="entry name" value="RNA_pol_Rpb1_7_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR038120">
<property type="entry name" value="Rpb1_funnel_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF04997">
<property type="entry name" value="RNA_pol_Rpb1_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00623">
<property type="entry name" value="RNA_pol_Rpb1_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04983">
<property type="entry name" value="RNA_pol_Rpb1_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05000">
<property type="entry name" value="RNA_pol_Rpb1_4"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04998">
<property type="entry name" value="RNA_pol_Rpb1_5"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04992">
<property type="entry name" value="RNA_pol_Rpb1_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF04990">
<property type="entry name" value="RNA_pol_Rpb1_7"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF05001">
<property type="entry name" value="RNA_pol_Rpb1_R"/>
<property type="match status" value="42"/>
</dbReference>
<dbReference type="SMART" id="SM00663">
<property type="entry name" value="RPOLA_N"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00115">
<property type="entry name" value="RNA_POL_II_REPEAT"/>
<property type="match status" value="42"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0240">DNA-directed RNA polymerase</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0548">Nucleotidyltransferase</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0696">RNA-directed RNA polymerase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="chain" description="DNA-directed RNA polymerase II subunit RPB1" id="PRO_0000073940">
<location>
<begin position="1"/>
<end position="1970"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="1593"/>
<end position="1599"/>
</location>
</feature>
<feature type="repeat" description="2; approximate">
<location>
<begin position="1600"/>
<end position="1606"/>
</location>
</feature>
<feature type="repeat" description="3">
<location>
<begin position="1608"/>
<end position="1614"/>
</location>
</feature>
<feature type="repeat" description="4">
<location>
<begin position="1615"/>
<end position="1621"/>
</location>
</feature>
<feature type="repeat" description="5">
<location>
<begin position="1622"/>
<end position="1628"/>
</location>
</feature>
<feature type="repeat" description="6">
<location>
<begin position="1629"/>
<end position="1635"/>
</location>
</feature>
<feature type="repeat" description="7">
<location>
<begin position="1636"/>
<end position="1642"/>
</location>
</feature>
<feature type="repeat" description="8">
<location>
<begin position="1643"/>
<end position="1649"/>
</location>
</feature>
<feature type="repeat" description="9">
<location>
<begin position="1650"/>
<end position="1656"/>
</location>
</feature>
<feature type="repeat" description="10">
<location>
<begin position="1657"/>
<end position="1663"/>
</location>
</feature>
<feature type="repeat" description="11">
<location>
<begin position="1664"/>
<end position="1670"/>
</location>
</feature>
<feature type="repeat" description="12">
<location>
<begin position="1671"/>
<end position="1677"/>
</location>
</feature>
<feature type="repeat" description="13">
<location>
<begin position="1678"/>
<end position="1684"/>
</location>
</feature>
<feature type="repeat" description="14">
<location>
<begin position="1685"/>
<end position="1691"/>
</location>
</feature>
<feature type="repeat" description="15">
<location>
<begin position="1692"/>
<end position="1698"/>
</location>
</feature>
<feature type="repeat" description="16">
<location>
<begin position="1699"/>
<end position="1705"/>
</location>
</feature>
<feature type="repeat" description="17">
<location>
<begin position="1706"/>
<end position="1712"/>
</location>
</feature>
<feature type="repeat" description="18">
<location>
<begin position="1713"/>
<end position="1719"/>
</location>
</feature>
<feature type="repeat" description="19">
<location>
<begin position="1720"/>
<end position="1726"/>
</location>
</feature>
<feature type="repeat" description="20">
<location>
<begin position="1727"/>
<end position="1733"/>
</location>
</feature>
<feature type="repeat" description="21">
<location>
<begin position="1734"/>
<end position="1740"/>
</location>
</feature>
<feature type="repeat" description="22">
<location>
<begin position="1741"/>
<end position="1747"/>
</location>
</feature>
<feature type="repeat" description="23">
<location>
<begin position="1748"/>
<end position="1754"/>
</location>
</feature>
<feature type="repeat" description="24">
<location>
<begin position="1755"/>
<end position="1761"/>
</location>
</feature>
<feature type="repeat" description="25">
<location>
<begin position="1762"/>
<end position="1768"/>
</location>
</feature>
<feature type="repeat" description="26">
<location>
<begin position="1769"/>
<end position="1775"/>
</location>
</feature>
<feature type="repeat" description="27">
<location>
<begin position="1776"/>
<end position="1782"/>
</location>
</feature>
<feature type="repeat" description="28">
<location>
<begin position="1783"/>
<end position="1789"/>
</location>
</feature>
<feature type="repeat" description="29">
<location>
<begin position="1790"/>
<end position="1796"/>
</location>
</feature>
<feature type="repeat" description="30">
<location>
<begin position="1797"/>
<end position="1803"/>
</location>
</feature>
<feature type="repeat" description="31">
<location>
<begin position="1804"/>
<end position="1810"/>
</location>
</feature>
<feature type="repeat" description="32">
<location>
<begin position="1811"/>
<end position="1817"/>
</location>
</feature>
<feature type="repeat" description="33">
<location>
<begin position="1818"/>
<end position="1824"/>
</location>
</feature>
<feature type="repeat" description="34">
<location>
<begin position="1825"/>
<end position="1831"/>
</location>
</feature>
<feature type="repeat" description="35">
<location>
<begin position="1832"/>
<end position="1838"/>
</location>
</feature>
<feature type="repeat" description="36">
<location>
<begin position="1839"/>
<end position="1845"/>
</location>
</feature>
<feature type="repeat" description="37">
<location>
<begin position="1846"/>
<end position="1852"/>
</location>
</feature>
<feature type="repeat" description="38">
<location>
<begin position="1853"/>
<end position="1859"/>
</location>
</feature>
<feature type="repeat" description="39">
<location>
<begin position="1860"/>
<end position="1866"/>
</location>
</feature>
<feature type="repeat" description="40">
<location>
<begin position="1867"/>
<end position="1873"/>
</location>
</feature>
<feature type="repeat" description="41">
<location>
<begin position="1874"/>
<end position="1880"/>
</location>
</feature>
<feature type="repeat" description="42">
<location>
<begin position="1881"/>
<end position="1887"/>
</location>
</feature>
<feature type="repeat" description="43">
<location>
<begin position="1888"/>
<end position="1894"/>
</location>
</feature>
<feature type="repeat" description="44">
<location>
<begin position="1895"/>
<end position="1901"/>
</location>
</feature>
<feature type="repeat" description="45">
<location>
<begin position="1902"/>
<end position="1908"/>
</location>
</feature>
<feature type="repeat" description="46">
<location>
<begin position="1909"/>
<end position="1915"/>
</location>
</feature>
<feature type="repeat" description="47">
<location>
<begin position="1916"/>
<end position="1922"/>
</location>
</feature>
<feature type="repeat" description="48">
<location>
<begin position="1923"/>
<end position="1929"/>
</location>
</feature>
<feature type="repeat" description="49">
<location>
<begin position="1930"/>
<end position="1936"/>
</location>
</feature>
<feature type="repeat" description="50">
<location>
<begin position="1940"/>
<end position="1946"/>
</location>
</feature>
<feature type="repeat" description="51; approximate">
<location>
<begin position="1947"/>
<end position="1953"/>
</location>
</feature>
<feature type="repeat" description="52; approximate">
<location>
<begin position="1954"/>
<end position="1960"/>
</location>
</feature>
<feature type="region of interest" description="Bridging helix">
<location>
<begin position="833"/>
<end position="845"/>
</location>
</feature>
<feature type="region of interest" description="C-terminal domain (CTD); 52 X 7 AA approximate tandem repeats of Y-[ST]-P-[STQ]-[ST]-P-[SRTEVKGN]">
<location>
<begin position="1593"/>
<end position="1960"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="71"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="74"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="81"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="9">
<location>
<position position="84"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="111"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="114"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="154"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="9">
<location>
<position position="184"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1; catalytic" evidence="9">
<location>
<position position="495"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2; shared with RPB2" evidence="9">
<location>
<position position="495"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1; catalytic" evidence="9">
<location>
<position position="497"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 2; shared with RPB2" evidence="9">
<location>
<position position="497"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Magnesium 1; catalytic" evidence="9">
<location>
<position position="499"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="4">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="27"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="217"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylated arginine; by CARM1; in vitro" evidence="48">
<location>
<position position="1603"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate; by CARM1" evidence="35 48">
<location>
<position position="1810"/>
</location>
</feature>
<feature type="modified residue" description="Symmetric dimethylarginine; alternate; by PRMT5" evidence="48">
<location>
<position position="1810"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="10">
<location>
<position position="1838"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="10">
<location>
<position position="1838"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1840"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 46">
<location>
<position position="1843"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="46">
<location>
<position position="1845"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1847"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 46">
<location>
<position position="1849"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 46">
<location>
<position position="1850"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="5">
<location>
<position position="1854"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="46">
<location>
<position position="1857"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="46">
<location>
<position position="1859"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="46">
<location>
<position position="1859"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="46">
<location>
<position position="1860"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="46">
<location>
<position position="1861"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1863"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7 46">
<location>
<position position="1864"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6,N6-trimethyllysine; alternate" evidence="46">
<location>
<position position="1866"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="46">
<location>
<position position="1866"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="46">
<location>
<position position="1866"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="46">
<location>
<position position="1866"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="46">
<location>
<position position="1867"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="1868"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1870"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6,N6-trimethyllysine; alternate" evidence="46">
<location>
<position position="1873"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="10">
<location>
<position position="1873"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="46">
<location>
<position position="1873"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="3 8 46">
<location>
<position position="1874"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="46">
<location>
<position position="1875"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1877"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7 46">
<location>
<position position="1878"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="46">
<location>
<position position="1881"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7 46">
<location>
<position position="1882"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="7">
<location>
<position position="1885"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="10">
<location>
<position position="1887"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="46">
<location>
<position position="1887"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="46">
<location>
<position position="1887"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="10">
<location>
<position position="1894"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="1896"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 7">
<location>
<position position="1899"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="1906"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine" evidence="10">
<location>
<position position="1908"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="2 3 8 46">
<location>
<position position="1909"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1912"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 7 46">
<location>
<position position="1913"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1915"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="46">
<location>
<position position="1916"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 46">
<location>
<position position="1917"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1919"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 7 46">
<location>
<position position="1920"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="10">
<location>
<position position="1922"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="56">
<location>
<position position="1922"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="56">
<location>
<position position="1922"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="2 3 8 46">
<location>
<position position="1923"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1926"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 7 46">
<location>
<position position="1927"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1929"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="46">
<location>
<position position="1930"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 46">
<location>
<position position="1931"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="46">
<location>
<position position="1933"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5 7">
<location>
<position position="1934"/>
</location>
</feature>
<feature type="modified residue" description="N6,N6-dimethyllysine; alternate" evidence="10">
<location>
<position position="1936"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="56">
<location>
<position position="1936"/>
</location>
</feature>
<feature type="modified residue" description="N6-methyllysine; alternate" evidence="56">
<location>
<position position="1936"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056184" evidence="53">
<original>GEVMNLLMF</original>
<variation>VCGPNGNLA</variation>
<location>
<begin position="558"/>
<end position="566"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_056185" evidence="53">
<location>
<begin position="567"/>
<end position="1970"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2229198." id="VAR_051872">
<original>R</original>
<variation>C</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; mild; unknown pathological significance." id="VAR_082988" evidence="50">
<original>P</original>
<variation>L</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; severe; unknown pathological significance; no effect on cell viability." id="VAR_082989" evidence="50">
<original>I</original>
<variation>T</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; unknown pathological significance; no effect on cell viability." id="VAR_082990" evidence="50">
<original>N</original>
<variation>S</variation>
<location>
<position position="531"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; moderate." id="VAR_082991" evidence="50">
<location>
<position position="669"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; mild." id="VAR_082992" evidence="50">
<location>
<begin position="700"/>
<end position="1970"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; mild." id="VAR_082993" evidence="50">
<location>
<begin position="735"/>
<end position="1970"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; profound; decreased cell viability." id="VAR_082994" evidence="50">
<original>T</original>
<variation>M</variation>
<location>
<position position="736"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; mild; unknown pathological significance; decreased cell viability." id="VAR_082995" evidence="50">
<location>
<position position="755"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; severe; unknown pathological significance." id="VAR_082996" evidence="50">
<original>M</original>
<variation>T</variation>
<location>
<position position="769"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; moderate; unknown pathological significance." id="VAR_082997" evidence="50">
<original>I</original>
<variation>T</variation>
<location>
<position position="848"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; moderate; unknown pathological significance." id="VAR_082998" evidence="50">
<original>Y</original>
<variation>H</variation>
<location>
<position position="1109"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; mild; decreased cell viability." id="VAR_082999" evidence="50">
<original>L</original>
<variation>P</variation>
<location>
<position position="1124"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; mild; unknown pathological significance." id="VAR_083000" evidence="50">
<location>
<position position="1125"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; severe; unknown pathological significance; no effect on cell viability." id="VAR_083001" evidence="50">
<original>N</original>
<variation>S</variation>
<location>
<position position="1251"/>
</location>
</feature>
<feature type="sequence variant" description="In NEDHIB; moderate; unknown pathological significance; no effect on cell viability." id="VAR_083002" evidence="50">
<original>R</original>
<variation>H</variation>
<location>
<position position="1603"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases cell viability." evidence="50">
<location>
<begin position="812"/>
<end position="1970"/>
</location>
</feature>
<feature type="mutagenesis site" description="Misexpression of a variety of small nuclear RNAs and small nucleolar RNAs. Loss of interaction with TDRD3 and SMN1/SMN2." evidence="35 48">
<original>R</original>
<variation>A</variation>
<location>
<position position="1810"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R-1859; R-1866; R-1873; R-1887; R-1908; R-1922 and R-1936." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1838"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R-1838; R-1866; R-1873; R-1887; R-1908; R-1922 and R-1936." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1859"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R-1859; R-1859; R-1873; R-1887; R-1908; R-1922 and R-1936." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1866"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R-1838; R-1859; R-1866; R-1887; R-1908; R-1922 and R-1936." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1873"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R-1838; R-1859; R-1866; R-1873; R-1908; R-1922 and R-1936." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1887"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R.1838; R-1859; R-1866; R-1873; R-1887; R-1922 and R-1936." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1908"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R-1838; R-1859; R-1866; R-1873; R-1887; R-1908 and R-1936." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1922"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of acetylation and loss of regulation of growth-factor-induced gene expression; when associated with R-1838; R-1859; R-1866; R-1873; R-1887; R-1908 and R-1922." evidence="43">
<original>K</original>
<variation>R</variation>
<location>
<position position="1936"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA52862." ref="2" evidence="55">
<original>W</original>
<variation>L</variation>
<location>
<position position="1067"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; CAA52862." ref="2" evidence="55">
<original>D</original>
<variation>Y</variation>
<location>
<position position="1449"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; CAA45125 and 2; CAA52862." ref="1 2" evidence="55">
<original>A</original>
<variation>T</variation>
<location>
<position position="1835"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1722"/>
<end position="1724"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5M3H"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P08775"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10393184"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10454543"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12376575"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12381297"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12527917"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14684736"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14992727"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15563843"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15992770"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16118227"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16314571"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16491129"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17157258"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17234882"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17998332"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18032511"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18533109"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18550522"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19106100"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19136461"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19450536"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19667075"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20231364"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21127351"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21454787"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21536736"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22137580"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22466610"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23029222"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23149945"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23652018"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23748380"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24207025"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24656813"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26124092"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26566685"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26687004"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26700805"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28076779"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31353023"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9671816"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9852112"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="22137580"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000305"/>
<evidence key="56" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26566685"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:9187"/>
</source>
</evidence>
<sequence length="1970" mass="217176" checksum="28D6FD25693A6472" modified="2009-12-15" version="2">MHGGGPPSGDSACPLRTIKRVQFGVLSPDELKRMSVTEGGIKYPETTEGGRPKLGGLMDPRQGVIERTGRCQTCAGNMTECPGHFGHIELAKPVFHVGFLVKTMKVLRCVCFFCSKLLVDSNNPKIKDILAKSKGQPKKRLTHVYDLCKGKNICEGGEEMDNKFGVEQPEGDEDLTKEKGHGGCGRYQPRIRRSGLELYAEWKHVNEDSQEKKILLSPERVHEIFKRISDEECFVLGMEPRYARPEWMIVTVLPVPPLSVRPAVVMQGSARNQDDLTHKLADIVKINNQLRRNEQNGAAAHVIAEDVKLLQFHVATMVDNELPGLPRAMQKSGRPLKSLKQRLKGKEGRVRGNLMGKRVDFSARTVITPDPNLSIDQVGVPRSIAANMTFAEIVTPFNIDRLQELVRRGNSQYPGAKYIIRDNGDRIDLRFHPKPSDLHLQTGYKVERHMCDGDIVIFNRQPTLHKMSMMGHRVRILPWSTFRLNLSVTTPYNADFDGDEMNLHLPQSLETRAEIQELAMVPRMIVTPQSNRPVMGIVQDTLTAVRKFTKRDVFLERGEVMNLLMFLSTWDGKVPQPAILKPRPLWTGKQIFSLIIPGHINCIRTHSTHPDDEDSGPYKHISPGDTKVVVENGELIMGILCKKSLGTSAGSLVHISYLEMGHDITRLFYSNIQTVINNWLLIEGHTIGIGDSIADSKTYQDIQNTIKKAKQDVIEVIEKAHNNELEPTPGNTLRQTFENQVNRILNDARDKTGSSAQKSLSEYNNFKSMVVSGAKGSKINISQVIAVVGQQNVEGKRIPFGFKHRTLPHFIKDDYGPESRGFVENSYLAGLTPTEFFFHAMGGREGLIDTAVKTAETGYIQRRLIKSMESVMVKYDATVRNSINQVVQLRYGEDGLAGESVEFQNLATLKPSNKAFEKKFRFDYTNERALRRTLQEDLVKDVLSNAHIQNELEREFERMREDREVLRVIFPTGDSKVVLPCNLLRMIWNAQKIFHINPRLPSDLHPIKVVEGVKELSKKLVIVNGDDPLSRQAQENATLLFNIHLRSTLCSRRMAEEFRLSGEAFDWLLGEIESKFNQAIAHPGEMVGALAAQSLGEPATQMTLNTFHYAGVSAKNVTLGVPRLKELINISKKPKTPSLTVFLLGQSARDAERAKDILCRLEHTTLRKVTANTAIYYDPNPQSTVVAEDQEWVNVYYEMPDFDVARISPWLLRVELDRKHMTDRKLTMEQIAEKINAGFGDDLNCIFNDDNAEKLVLRIRIMNSDENKMQEEEEVVDKMDDDVFLRCIESNMLTDMTLQGIEQISKVYMHLPQTDNKKKIIITEDGEFKALQEWILETDGVSLMRVLSEKDVDPVRTTSNDIVEIFTVLGIEAVRKALERELYHVISFDGSYVNYRHLALLCDTMTCRGHLMAITRHGVNRQDTGPLMKCSFEETVDVLMEAAAHGESDPMKGVSENIMLGQLAPAGTGCFDLLLDAEKCKYGMEIPTNIPGLGAAGPTGMFFGSAPSPMGGISPAMTPWNQGATPAYGAWSPSVGSGMTPGAAGFSPSAASDASGFSPGYSPAWSPTPGSPGSPGPSSPYIPSPGGAMSPSYSPTSPAYEPRSPGGYTPQSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYSPTSPNYTPTSPSYSPTSPSYSPTSPNYTPTSPNYSPTSPSYSPTSPSYSPTSPSYSPSSPRYTPQSPTYTPSSPSYSPSSPSYSPASPKYTPTSPSYSPSSPEYTPTSPKYSPTSPKYSPTSPKYSPTSPTYSPTTPKYSPTSPTYSPTSPVYTPTSPKYSPTSPTYSPTSPKYSPTSPTYSPTSPKGSTYSPTSPGYSPTSPTYSLTSPAISPDDSDEEN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

